Late outcome after intracoronary beta radiation brachytherapy: A matched-propensity controlled ten-year follow-up study

EuroIntervention

Volumn 6, Issue 6, 2011, Pages 695-702

  Cheng, Jin M ^a   Onuma, Yoshinobu ^a   Eindhoven, Jannet ^a   Levendag, Peter C ^a   Serruys, Patrick W ^a   Van Domburg, Ron T ^a   Van Der Giessen, Wim J ^a  

^a ERASMUS MEDICAL CENTER   (Netherlands)

Author keywords

Coronary artery disease; Intracoronary radiation brachytherapy; Percutaneous coronary intervention

Indexed keywords

ADULT; ARTICLE; BETA RADIATION; BRACHYTHERAPY; CAUSE OF DEATH; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISEASE FREE SURVIVAL; EVENT FREE SURVIVAL; FEMALE; FOLLOW UP; HEART INFARCTION; HUMAN; IN-STENT RESTENOSIS; MAJOR CLINICAL STUDY; MALE; MORTALITY; OUTCOME ASSESSMENT; PERCUTANEOUS CORONARY INTERVENTION; REVASCULARIZATION; SCORING SYSTEM; SURVIVAL TIME; TREATMENT DURATION;

ANGIOPLASTY, BALLOON, CORONARY; BRACHYTHERAPY; CASE-CONTROL STUDIES; CHI-SQUARE DISTRIBUTION; CORONARY ARTERY DISEASE; DISEASE-FREE SURVIVAL; FOLLOW-UP STUDIES; HUMANS; KAPLAN-MEIER ESTIMATE; LOGISTIC MODELS; MYOCARDIAL INFARCTION; NETHERLANDS; PHOSPHORUS RADIOISOTOPES; PROPENSITY SCORE; PROPORTIONAL HAZARDS MODELS; PROSPECTIVE STUDIES; RISK ASSESSMENT; RISK FACTORS; STRONTIUM RADIOISOTOPES; SURVIVAL RATE; TIME FACTORS; TREATMENT OUTCOME; YTTRIUM RADIOISOTOPES;

EID: 79954490269     PISSN: 1774024X     EISSN: 19696213     Source Type: Journal    
DOI: 10.4244/EIJV6I6A118     Document Type: Article

References (44)

1. Serruys PW, de Jaegere P, Kiemeneij F, Macaya C, Rutsch W, Heyndrickx G, Emanuelsson H, Marco J, Legrand V, Materne P, Belardi B, Sigwart U, Colombo A, Goy JJ,van den Heuvel P, Delcan J, Morel MA for the Benestent Study Group. A comparison of balloon-expandable-stent implantation with balloon angioplasty in patients with coronary artery disease. Benestent Study Group. N Engl J Med 1994;331:489-495. (Pubitemid 24256751)
2. Teirstein PS, Massullo V, Jani S, Popma JJ, Mintz GS, Russo RJ, Schatz RA, Guarneri EM, Steuterman S, Morris NB, Leon MB, Tripuraneni P. Catheter-based radiotherapy to inhibit restenosis after coronary stenting. N Engl J Med 1997;336:1697-1703. (Pubitemid 27251783)
3. Waksman R, White RL, Chan RC, Bass BG, Geirlach L, Mintz GS, Satler LF, Mehran R, Serruys PW, Lansky AJ, Fitzgerald P, Bhargava B, Kent KM, Pichard AD, Leon MB. Intracoronary gamma-radiation therapy after angioplasty inhibits recurrence in patients with in-stent restenosis. Circulation 2000;101:2165-2171. (Pubitemid 30253045)
4. Leon MB, Teirstein PS, Moses JW, Tripuraneni P, Lansky AJ, Jani S, Wong SC, Fish D, Ellis S, Holmes DR, Kerieakes D, Kuntz RE. Localized intracoronary gamma-radiation therapy to inhibit the recurrence of restenosis after stenting. N Engl J Med 2001;344:250-256. (Pubitemid 32108529)
5. Waksman R, Bhargava B, White L, Chan RC, Mehran R, Lansky AJ, Mintz GS, Satler LF, Pichard AD, Leon MB, Kent KK. Intracoronary betaradiation therapy inhibits recurrence of in-stent restenosis. Circulation 2000;101:1895-1898. (Pubitemid 30225268)
6. Popma JJ, Suntharalingam M, Lansky AJ, Heuser RR, Speiser B, Teirstein PS, Massullo V, Bass T, Henderson R, Silber S, von Rottkay P, Bonan R, Ho KK, Osattin A, Kuntz RE. Randomized trial of 90Sr/90Y betaradiation versus placebo control for treatment of in-stent restenosis. Circulation 2002;106:1090-1096. (Pubitemid 34970849)
7. Waksman R, Raizner AE, Yeung AC, Lansky AJ, Vandertie L. Use of localised intracoronary beta radiation in treatment of in-stent restenosis: the INHIBIT randomised controlled trial. Lancet 2002;359:551-557. (Pubitemid 34178435)
8. Verin V, Popowski Y, de Bruyne B, Baumgart D, Sauerwein W, Lins M, Kovacs G, Thomas M, Calman F, Disco C, Serruys PW, Wijns W. Endoluminal beta-radiation therapy for the prevention of coronary restenosis after balloon angioplasty. The Dose-Finding Study Group. N Engl J Med 2001;344:243-249. (Pubitemid 32108528)
9. Serruys PW, Sianos G, van der Giessen W, Bonnier HJ, Urban P, Wijns W, Benit E, Vandormael M, Dorr R, Disco C, Debbas N, Silber S. Intracoronary beta-radiation to reduce restenosis after balloon angioplasty and stenting; the Beta Radiation In Europe (BRIE) study. Eur Heart J 2002;23:1351-1359. (Pubitemid 35407616)
10. Kuntz R, Speiser B, Joyal M. Clinical and angiographical outcomes after use of Sr-90 beta-radiation for the treatment of de novo and restenotic coronary lesions. Congress of the American College of Cardiology, Orlando, March 2001.
11. Serruys PW, Wijns W, Sianos G, de Scheerder I, van den Heuvel PA, Rutsch W, Glogar HD, Macaya C, Materne PH, Veldhof S, Vonhausen H, Otto-Terlouw PC, van der Giessen WJ. Direct stenting versus direct stenting followed by centered beta-radiation with intravascular ultrasound-guided dosimetry and long-term anti-platelet treatment: results of a randomized trial: Beta-Radiation Investigation with Direct Stenting and Galileo in Europe (BRIDGE). J Am Coll Cardiol 2004;44:528-537. (Pubitemid 39078174)
12. Ferrero V, Ribichini F, Piessens M, Heyndrickx GR, Verbeke L, de Bruyne B, Feola M, Vassanelli C, Wijns W. Intracoronary beta-irradiation for the treatment of de novo lesions: 5-year clinical follow-up of the BetAce randomized trial. Am Heart J 2007;153:398-402. (Pubitemid 46328752)
13. Sianos G, Kay IP, Costa MA, Regar E, Kozuma K, de Feyter PJ, Boersma E, Disco C, Serruys PW. Geographical miss during catheter-based intracoronary beta-radiation: incidence and implications in the BRIE study. Beta-Radiation In Europe. J Am Coll Cardiol 2001;38:415-420. (Pubitemid 32721769)
14. Sianos G, Hoye A, Saia F, van der Giessen W, Lemos P, de Feyter PJ, Levendag PC, van Domburg R, Serruys PW. Long term outcome after intracoronary beta radiation therapy. Heart 2005;91:942-947. (Pubitemid 40874087)
15. Silber S, Albertsson P, Aviles FF, Camici PG, Colombo A, Hamm C, Jorgensen E, Marco J, Nordrehaug JE, Ruzyllo W, Urban P, Stone GW, Wijns W. Guidelines for percutaneous coronary interventions. The Task Force for Percutaneous Coronary Interventions of the European Society of Cardiology. Eur Heart J 2005;26:804-847. (Pubitemid 40547082)
16. Smith SC, Jr., Feldman TE, Hirshfeld JW, Jr., Jacobs AK, Kern MJ, King SB, 3rd, Morrison DA, O'Neill WW, Schaff HV, Whitlow PL, Williams DO, Antman EM, Adams CD, Anderson JL, Faxon DP, Fuster V, Halperin JL, Hiratzka LF, Hunt SA, Nishimura R, Ornato JP, Page RL, Riegel B. ACC/AHA/SCAI 2005 guideline update for percutaneous coronary intervention: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (ACC/AHA/SCAI Writing Committee to Update the 2001 Guidelines for Percutaneous Coronary Intervention). J Am Coll Cardiol 2006;47:e1-121.
17. Urban P, Serruys P, Baumgart D, Colombo A, Silber S, Eeckhout E, Gershlick A, Wegscheider K, Verhees L, Bonan R. A multicentre European registry of intraluminal coronary beta brachytherapy. Eur Heart J 2003;24:604-612. (Pubitemid 36343193)
18. Coen V, Serruys P, Sauerwein W, Orecchia R, Von Rottkay P, Coucke P, Ehnert M, Urban P, Bonan R, Levendag P. Reno, a European postmarket surveillance registry, confirms effectiveness of coronary brachytherapy in routine clinical practice. Int J Radiat Oncol Biol Phys 2003;55:1019-1026. (Pubitemid 36287006)
19. Silber S, Popma JJ, Suntharalingam M, Lansky AJ, Heuser RR, Speiser B, Teirstein PS, Bass T, O'Neill W, Lasala J, Reisman M, Sharma SK, Kuntz RE, Bonan R. Two-year clinical follow-up of 90Sr/90 Y beta-radiation versus placebo control for the treatment of in-stent restenosis. Am Heart J 2005;149:689-694.
20. Teirstein PS, Massullo V, Jani S, Popma JJ, Russo RJ, Schatz RA, Guarneri EM, Steuterman S, Sirkin K, Cloutier DA, Leon MB, Tripuraneni P. Three-year clinical and angiographic follow-up after intracoronary radiation: results of a randomized clinical trial. Circulation 2000;101:360-365. (Pubitemid 30067390)
21. Grise MA, Massullo V, Jani S, Popma JJ, Russo RJ, Schatz RA, Guarneri EM, Steuterman S, Cloutier DA, Leon MB, Tripuraneni P, Teirstein PS. Five-year clinical follow-up after intracoronary radiation: results of a randomized clinical trial. Circulation 2002;105:2737-2740. (Pubitemid 34615144)
22. Ajani AE, Waksman R, Sharma AK, Cha DH, Cheneau E, White RL, Canos D, Pichard AD, Satler LF, Kent KM, Pinnow E, Lindsay J. Three-year follow-up after intracoronary gamma radiation therapy for in-stent restenosis. Original WRIST. Washington Radiation for In-Stent Restenosis Trial. Cardiovasc Radiat Med 2001;2:200-204.
23. Waksman R, Ajani AE, White RL, Chan R, Bass B, Pichard AD, Satler LF, Kent KM, Torguson R, Deible R, Pinnow E, Lindsay J. Five-year follow-up after intracoronary gamma radiation therapy for in-stent restenosis. Circulation 2004;109:340-344. (Pubitemid 38133901)
24. Cutlip DE, Windecker S, Mehran R, Boam A, Cohen DJ, van Es GA, Steg PG, Morel MA, Mauri L, Vranckx P, McFadden E, Lansky A, Hamon M, Krucoff MW, Serruys PW. Clinical end points in coronary stent trials: a case for standardized definitions. Circulation 2007;115:2344-2351. (Pubitemid 46685903)
25. Alpert JS, Thygesen K, Antman E, Bassand JP. Myocardial infarction redefined - a consensus document of The Joint European Society of Cardiology/American College of Cardiology Committee for the redefinition of myocardial infarction. J Am Coll Cardiol 2000;36:959-969.
26. Rosenbaum PR, Rubin DR. The central role of the propensity score in observational studies for causal effects. Biometrica 1983;70:41-55.
27. Connors AF, Jr., Speroff T, Dawson NV, Thomas C, Harrell FE, Jr., Wagner D, Desbiens N, Goldman L, Wu AW, Califf RM, Fulkerson WJ, Jr., Vidaillet H, Broste S, Bellamy P, Lynn J, Knaus WA. The effectiveness of right heart catheterization in the initial care of critically ill patients. SUPPORT Investigators. JAMA 1996;276:889-897. (Pubitemid 26301608)
28. Stenestrand U, Wallentin L. Early statin treatment following acute myocardial infarction and 1-year survival. JAMA 2001;285:430-436. (Pubitemid 32097261)
29. King SB, 3rd, Williams DO, Chougule P, Klein JL, Waksman R, Hilstead R, Macdonald J, Anderberg K, Crocker IR. Endovascular betaradiation to reduce restenosis after coronary balloon angioplasty: results of the beta energy restenosis trial (BERT). Circulation 1998;97:2025-2030. (Pubitemid 28243664)
30. Raizner AE, Oesterle SN, Waksman R, Serruys PW, Colombo A, Lim YL, Yeung AC, van der Giessen WJ, Vandertie L, Chiu JK, White LR, Fitzgerald PJ, Kaluza GL, Ali NM. Inhibition of restenosis with beta-emitting radiotherapy: Report of the Proliferation Reduction with Vascular Energy Trial (PREVENT). Circulation 2000;102:951-958. (Pubitemid 30656002)
31. Teirstein PS, Kuntz RE. New frontiers in interventional cardiology: intravascular radiation to prevent restenosis. Circulation 2001;104:2620-2626. (Pubitemid 33104803)
32. Meerkin D, Joyal M, Tardif JC, Lesperance J, Arsenault A, Lucier G, Bonan R. Two-year angiographic follow-up of intracoronary Sr90 therapy for restenosis prevention after balloon angioplasty. Circulation 2002;106:539-543. (Pubitemid 34827701)
33. Waksman R, Bhargava B, Mintz GS, Mehran R, Lansky AJ, Satler LF, Pichard AD, Kent KM, Leon MB. Late total occlusion after intracoronary brachytherapy for patients with in-stent restenosis. J Am Coll Cardiol 2000;36:65-68. (Pubitemid 30466113)
34. Costa MA, Sabate M, van der Giessen WJ, Kay IP, Cervinka P, Ligthart JM, Serrano P, Coen VL, Levendag PC, Serruys PW. Late coronary occlusion after intracoronary brachytherapy. Circulation 1999;100:789-792. (Pubitemid 29398874)
35. van Der Giessen WJ, Regar E, Harteveld MS, Coen VL, Bhagwandien R, Au A, Levendag PC, Ligthart J, Serruys PW, den Boer A, Verdouw PD, Boersma E, Hu T, van Beusekom HM. "Edge Effect" of (32)p radioactive stents is caused by the combination of chronic stent injury and radioactive dose falloff. Circulation 2001;104:2236-2241.
36. Waksman R, Ajani AE, Pinnow E, Cheneau E, Leborgne L, Dieble R, Bui AB, Satler LF, Pichard AD, Kent KK, Lindsay J. Twelve versus six months of clopidogrel to reduce major cardiac events in patients undergoing gamma-radiation therapy for in-stent restenosis: Washington Radiation for In-Stent restenosis Trial (WRIST) 12 versus WRIST PLUS. Circulation 2002;106:776-778.
37. Milano MT, Constine LS, Okunieff P. Normal tissue toxicity after small field hypofractionated stereotactic body radiation. Radiat Oncol 2008;3:36.
38. Ritter M. Rationale, conduct, and outcome using hypofractionated radiotherapy in prostate cancer. Semin Radiat Oncol 2008;18:249-256.
39. Thomas MR. Brachytherapy: here today, gone tomorrow? Heart 2005;91Suppl 3:iii32-34.
40. Morice MC, Serruys PW, Sousa JE, Fajadet J, Ban Hayashi E, Perin M, Colombo A, Schuler G, Barragan P, Guagliumi G, Molnar F, Falotico R. A randomized comparison of a sirolimus-eluting stent with a standard stent for coronary revascularization. N Engl J Med 2002;346:1773-1780. (Pubitemid 34586912)
41. Dibra A, Kastrati A, Alfonso F, Seyfarth M, Perez-Vizcayno MJ, Mehilli J, Schomig A. Effectiveness of drug-eluting stents in patients with bare-metal in-stent restenosis: meta-analysis of randomized trials. J Am Coll Cardiol 2007;49:616-623. (Pubitemid 46177448)
42. Ellis SG, O'Shaughnessy CD, Martin SL, Kent K, McGarry T, Turco MA, Kereiakes DJ, Popma JJ, Friedman M, Koglin J, Stone GW. Two-year clinical outcomes after paclitaxel-eluting stent or brachytherapy treatment for bare metal stent restenosis: the TAXUS V ISR trial. Eur Heart J 2008;29:1625-1634. (Pubitemid 351958446)
43. Holmes DR, Jr., Teirstein PS, Satler L, Sketch MH, Jr., Popma JJ, Mauri L, Wang HP, Schleckser PA, Cohen SA. 3-Year Follow-Up of the SISR (Sirolimus-Eluting Stents Versus Vascular Brachytherapy for In-Stent Restenosis) Trial. JACC Cardiovasc Interv 2008;1:439-448.
44. Bonello L, Kaneshige K, De Labriolle A, Roy P, Lemesle G, Torguson R, Satler LF, Pichard AD, Lindsay J, Waksman R. Vascular brachytherapy for patients with drug-eluting stent restenosis. J Interv Cardiol 2008;21:528-534.